Publications

5674 Results

Expanded phase II trial of paclitaxel in metastatic breast cancer: A Southwest Oncology Group study.

Authors
CE Geyer Jr;SJ Green;CM Moinpour;J O'Sullivan;DK Goodwin;VA Canfield;FJ Meyers;CK Osborne;S Martino
Journal / Conference
Breast Cancer Research and Treatment 51:169-181
Year
1998
Research Committee(s)
Breast
Study Number(s)
SWOG-9248

HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: A Southwest Oncology Group study.

Authors
RM Elledge;S Green;D Ciocca;R Pugh;DC Allred;GM Clark;J Hill;P Ravdin;J O'Sullivan;S Martino;CK Osborne
Journal / Conference
Clinical Cancer Research 4:7-12
Year
1998
Research Committee(s)
Breast
Study Number(s)
SWOG-9314

Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: A Southwest Oncology Group study.

Authors
KA Margolin;PY Liu;LE Flaherty;JA Sosman;MJ Walker;JW Smith II;WS Fletcher;GR Weiss;JM Unger;VK Sondak
Journal / Conference
Journal of Clinical Oncology 16(2):664-669
Year
1998
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9348

Evaluation of topotecan in resistant and relapsing multiple myeloma: A Southwest Oncology Group study.

Authors
EH Kraut;JJ Crowley;JL Wade;LR Laufman;M Alsina;SA Taylor;SE Salmon
Journal / Conference
Journal of Clinical Oncology 16(2):589-592
Year
1998
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9237

Phase II trial of recombinant human interleukin-4 in patients with disseminated malignant melanoma: A Southwest Oncology Group study.

Authors
RP Whitehead;JM Unger;JW Goodwin;MJ Walker;JA Thompson;LE Flaherty;VK Sondak
Journal / Conference
Journal of Immunotherapy 21(6):440-446
Year
1998
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9228

Interferon versus interferon plus prednisone remission maintenance therapy for multiple myeloma: A Southwest Oncology Group study.

Authors
SE Salmon;JJ Crowley;SP Balcerzak;RW Roach;SA Taylor;SE Rivkin;W Samlowski
Journal / Conference
Journal of Clinical Oncology 16(3):890-896
Year
1998
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9028

Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment.

Authors
G Falkson;RS Gelman;KJ Pandya;CK Osborne;D Tormey;FJ Cummings;GW Sledge;MD Abeloff
Journal / Conference
Journal of Clinical Oncology 16(5):1669-1676
Year
1998
Research Committee(s)
Breast
Study Number(s)
SWOG-8697 (INT-0077)

A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: A Southwest Oncology Group study (9031).

Authors
JE Godwin;KJ Kopecky;DR Head;CL Willman;CP Leith;HE Hynes;SP Balcerzak;FR Appelbaum
Journal / Conference
Blood 91(10):3607-3615
Year
1998
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9031

BCL-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: An Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory study.

Authors
JN Winter;J Andersen;JC Reed;S Krajewski;D Variakojis;KD Bauer;RI Fisher;LI Gordon;MM Oken;S Jiang;D Jeffries;P Domer
Journal / Conference
Blood 91(4):1391-1398
Year
1998
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8516 (INT-0067)

Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents.

Authors
DE Banker;M Groudine;CL Willman;T Norwood;FR Appelbaum
Journal / Conference
Leukemia Research 22(3):221-239
Year
1998